Douglas Woods, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3100 E 1st St, Chandler, OK 74834 Phone: 405-258-2012 Fax: 405-258-3095 |
Megan Coburn, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 913 Manvel Ave, Chandler, OK 74834 Phone: 405-258-1218 Fax: 405-258-2046 |
Richard Allen Covington, D.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 913 Manvel Ave, Chandler, OK 74834 Phone: 405-258-1218 Fax: 405-258-2046 |
Devin Lowe Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3100 E 1st St, Chandler, OK 74834 Phone: 405-258-2012 |
Callie Jean Hataway, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 913 Manvel Ave, Chandler, OK 74834 Phone: 405-258-1218 |
Edward Hutton Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3100 E 1st St, Chandler, OK 74834 Phone: 405-258-2012 |
News Archive
Aging-US published "Facility-based and home-based multidomain interventions including cognitive training, exercise, diet, vascular risk management, and motivation for older adults: a randomized controlled feasibility trial" which reported that in an outcome assessor-blinded, randomized controlled trial, participants without dementia and with one or more modifiable dementia risk factors, aged 60-79 years, were randomly assigned to the facility-based MI, the home-based MI, or the control group receiving general health advice.
An experimental cure for Type 1 diabetes has a nearly 80 percent success rate in curing diabetic mice. The results, to be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston, offer possible hope of curing a disease that affects 3 million Americans.
The preoperative neutrophil-to-lymphocyte ratio is associated with disease-free survival in patients undergoing resection of localized non-clear cell renal cell carcinoma, research shows.
For patients with clogged heart arteries who take long-term, low-dose aspirin to prevent a cardiac event, adding a stomach acid-blocking drug to their daily routine has been shown to reduce their risk for upper gastrointestinal bleeding - an infrequent, but serious side-effect of regular aspirin use.
Angiotech Pharmaceuticals, Inc. today announced that its corporate partner, Boston Scientific Corporation, announced 12-month results from its PERSEUS clinical program that demonstrated positive safety and efficacy outcomes in workhorse lesions for the platinum chromium TAXUS(R) Element(TM) Paclitaxel-Eluting Stent System compared to the TAXUS(R) Express(TM) Paclitaxel-Eluting Stent System.
› Verified 9 days ago